The Panther System


Master molecular workflow.

The Panther system consolidates a broad assay menu onto a single, fully automated platform.
  • Run HIV-1, HCV and HBV in parallel with sexually transmitted disease/sexually transmitted infection (STD/STI) testing assays on the Panther system: CT/NG, HPV and Trichomonas vaginalis.
  • Run up to 4 assays in parallel.
  • Deliver continuous results to physicians without waiting to fill a batch

Comprehensive information for complex coinfections.

Due to shared risk factors for transmission, an estimated 5 million people worldwide are coinfected with HIV and HCV.The Panther system streamlines testing when physicians ask for both HIV-1 and HCV testing.

From a single patient sample, the Panther system can:

  • Confirm active HCV infection in patients known to be infected with HIV-1.
  • Establish baseline HCV viral load.
  • Monitor HIV-1 viral load.


Leave the batch behind.

Deliver more same-day results to your customers with no batching restrictions.
  • Load samples as they arrive, in any order.
  • Prioritize and run urgent samples.
  • Run as few as 1 or as many as 94 clinical samples, with no additional controls required.

Unlock potential with random access.

Customize your workflow with random access on the Panther system.
  • Access the instrument at any time to load additional samples or reagents.
  • Continuous access so you can unload processed samples and load new samples as needed.
  • Unload and store reagents as needed to reduce waste.

Increase productivity with full automation.

Load and go with less hands-on time than any other viral load platform.
  • Load and process primary tubes (PPT, serum, SST, ACD and EDTA) directly on the Panther system.
  • No sample transfer or pipetting required.
  • No operator intervention necessary during a run.


Small footprint. Big possibilities.2-5

More results with less space: <1 square meter and over 300 results in less than 8 hours.
  • True sample-to-result automation: All sample processing, amplification and detection in one contained unit.
  • Potential to consolidate a broad assay menu onto one fully automated instrument.


References

  1. The Global Fund. Global Fund and Hepatitis C Treatment. The Global Fund Thirty-Second Board Meeting: November 20-21, 2014; Montreaux, Switzerland.
  2. Data on file. Hologic, Inc., 2014.
  3. UNITAID. HIV/AIDS Diagnostic Technology Landscape. 2nd ed. Geneva, Switzerland: World Health Organization; 2012.
  4. Ratnam S et al. Workflow and maintenance characteristics of five automated laboratory instruments for the diagnosis of sexually transmitted infections. J Clin Microbiol. 2014;52(7):2299-2304.
  5. Roche Molecular Diagnostics. Cobas 6800 System Specifications. https://www.cobas68008800.com/cobas_6800_details. Accessed August 17, 2015.